Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 395

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 395
---
 7.07 |     |             |     |     |           |     |
| Expired                             |     |                                                    |  (166 | ) |     | $         | 11.39 |     |             |     |     |           |     |
| Outstanding as of December 31, 2024 |     |                                                    | 2,331 |   |     | $         |  5.45 |     |             | 8.2 |     | $         |   — |
| Exercisable as of December 31, 2024 |     |                                                    | 1,295 |   |     | $         |  8.67 |     |             | 7.6 |     | $         |   — |

Annual Stock Awards and Employee Retention Policy On April 11, 2024, the Compensation Committee of the Board approved and on April 14, 2024, the Board approved and adopted the Annual Stock Awards and Employee Retention Policy (the “Policy”), which will provide retention awards to key employees, including certain of the Company’s named executive officers. Under the Policy, the Company’s former Chief Executive Officer and the Company’s Chair of the Board, Shawn Iadonato, Ph.D., the Company’s President, Craig W. Philips, the Company’s Chief Financial Officer, Keith A. F-141

KINETA, INC. Notes to Consolidated Financial Statements Baker, and the Company’s Chief Scientific Officer, Thierry Guillaudeux, Ph.D., received option awards to purchase 225,000, 225,000, 225,000 and 225,000 shares of the Company’s common stock, respectively. The awards are subject to three-part vesting: (i) 25% of the shares will vest upon award; (ii) 50% of shares will vest in the event of a Transaction or a Qualified Transaction, as such terms are defined in the Policy; and (iii) 25% of the shares will vest and become exercisable over the 36-monthperiod following the award on the one-monthanniversary of the vesting commencement date, subject to the optionee’s continued service through each vesting date. Nonrecourse Promissory Notes for Stock Options Exercised In March 2021, an employee exercised 56,000 vested stock options and entered into a nonrecourse promissory note in the amount of $0.4 million with the Company. The promissory